Pridopidine in Amyotrophic Lateral Sclerosis

Overview of attention for article published in JAMA: Journal of the American Medical Association, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 32 news outlets
blogs: 3 blogs
twitter: 10 X users
facebook: 3 Facebook pages

reddit: 1 Redditor
video: 1 YouTube creator
bluesky: 4 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 5 Bluesky posts from 4 Bluesky users, with an upper bound of 22,800 followers.

RP @jama.com: Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week study. https://ja.ma/4l9ukWO

Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week study. https://ja.ma/4l9ukWO

Pridopidine in ALS - HEALEY Platform Trial Outcome "In this 24-week study, pridopidine did not impact the progression of ALS" Is 6-months enough to see change? Healey now moving to 9-month trials - hopefully that will produce more definitive outcomes ja…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 1 additional Bluesky posts.